Controversies on Cannabis-Based Medicines​

Med-Cannabis2026 will address the many controversies surrounding cannabis-based medicines. Strong public and patient demand have led to the decision to allow cannabis products for medical use in most European countries. There is a lot of basic-science and clinical research on the potential use of cannabis products for chronic pain and cancer management as well as controversies on the potential harms.

This Congress will bring together physicians, researchers, clinicians, trialists, methodologists, industry professionals and national cannabis agencies to update the current state of knowledge and of controversies and to outline some visions of the potential of cannabis-based medicines.

The program will include a wealth of knowledge from our world-renowned panel of experts. We look forward to seeing you at Med-Cannabis2026 in the historic and charming city of Kraków.

Sincerely,